Joel Lewis Galectin Therapeutics Inc (GALT) insider trading activity

Joel Lewis is President and CEO of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 897,716 shares of GALT, which is worth approximately $2.44 Million. The most recent transaction as insider was on Jan 15, 2021, when has been sold 7,610 shares (Common Stock) at a price of $2.19 per share, resulting in proceeds of $16,666. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 898K

0% 3M change

11.01% 12M change

Total Value Held $2.44 Million

JOEL LEWIS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 15 2021	BUY Grant, award, or other acquisition	$16,666 $2.19 p/Share	7,610 Added 4.41%	165,021 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	$16,666 $2.24 p/Share	7,440 Added 4.51%	157,411 Common Stock
Dec 15 2020	BUY Grant, award, or other acquisition	$16,667 $2.52 p/Share	6,614 Added 4.22%	149,971 Common Stock
Nov 30 2020	BUY Grant, award, or other acquisition	$16,666 $2.6 p/Share	6,410 Added 4.28%	143,357 Common Stock
Nov 13 2020	BUY Grant, award, or other acquisition	$16,668 $2.75 p/Share	6,061 Added 4.24%	136,947 Common Stock
Oct 30 2020	BUY Grant, award, or other acquisition	$16,667 $2.54 p/Share	6,562 Added 4.77%	130,886 Common Stock
Oct 15 2020	BUY Grant, award, or other acquisition	$16,666 $2.87 p/Share	5,807 Added 4.46%	124,324 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	$16,666 $2.67 p/Share	6,242 Added 5.0%	118,517 Common Stock

Joel Lewis

President and CEO

Norcross, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Value

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

Operation

Value

Type

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT

Account